Cancer cases may rise to 1.57 mn from 1.39 mn in next 5 years: ICMR report

According to the statement, tobacco-related cancer is estimated to contribute 370,000 cases which is 27.1 per cent of the total cancer burden in 2020

Why aren't cancer drugs better? The targets might be wrong
Cancer incidence rate among males per 100,000 population ranges from 269.4 in Aizawl district, which is the highest in India, to 39.5 in Osmanabad and Beed districts.
Press Trust of India New Delhi
2 min read Last Updated : Aug 19 2020 | 8:29 AM IST

The number of cancer cases in India is estimated to be 1.39 million this year and may increase to 1.57 million by 2025, according to a report released by the ICMR and the Bengaluru-based National Centre for Disease Informatics and Research.

The Indian Council of Medical Research (ICMR) said the estimates presented in the National Cancer Registry Programme Report, 2020, are based on information collected from 28 Population Based Cancer Registries.

Additionally, 58 hospital-based cancer registries provided data, it said.

According to the statement, tobacco-related cancer is estimated to contribute 370,000 cases which is 27.1 per cent of the total cancer burden in 2020.

"Among women, breast cancer is estimated to contribute 200,000 (14.8 per cent) and cervix cancer is estimated to contribute 0.75 lakh (5.4 per cent), whereas for both men and women, cancers of the gastrointestinal tract is estimated to contribute 270,000 (19.7 per cent) of the total cancer burden," it said.

Cancer incidence rate among males per 100,000 population ranges from 269.4 in Aizawl district, which is the highest in India, to 39.5 in Osmanabad and Beed districts.

As for females, cancer incidence rate per 100,000 population ranges from 219.8 in Papumpare district to 49.4 in Osmanabad and Beed district, the statement said.

Incidence of cancer related to use of any form of tobacco was the highest in the northeastern region of the country and in higher proportion in men. Cancer of lung, mouth, stomach and oesophagus were the most common cancers among men, it highlighted.

Cancer of breast and cervix uteri were the most common cancers among women. Cancer of lung was diagnosed at a stage of spread to distant sites, while cancers of head and neck, stomach, breast and cervix were in higher proportions with loco-regional spread, the statement said.

Multimodality treatment -- a varied combination of surgery, chemotherapy and radiation therapy -- was administered for cancers of breast, and head and neck, while cancer of cervix was treated mainly with radiotherapy and chemotherapy.

For cancers of the lung and the stomach, systemic therapy was the mode of treatment, according to the ICMR statement.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :cancerICMRlung cancerbreast cancer

Next Story